Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trichoderma viride
- Development stage
- Unknown
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Intradermal, Topical, Seed Treatment, Soil Application
01
Overview
Trichoderma viride is a filamentous fungus widely used as a biofungicide and biological control agent in agriculture. It is applied to seeds and soil to suppress plant diseases caused by pathogenic fungi such as Rhizoctonia, Pythium, Fusarium species, Macrophomina phaseolina, and others. The mechanism of action involves competitive exclusion (outcompeting pathogens for space and nutrients), secretion of antifungal compounds (including cell wall-degrading enzymes and antibiotics), direct parasitism of pathogenic fungi, induction of systemic resistance in plants (triggering plant defense responses), and promotion of plant growth. In medicine, Trichoderma viride extract is used as a non-standardized fungal allergenic extract for allergy testing; it can provoke allergic reactions by increasing histamine release and stimulating cell-mediated immunity[1][2][3][6].
- Other names
- Trichoderma virideHypocrea rufa
Beyond the preview
Go deeper on Trichoderma viride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trichoderma viride.